Kayne Anderson Rudnick Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$276K Buy
3,524
+583
+20% +$45.6K ﹤0.01% 479
2025
Q1
$213K Buy
2,941
+1,916
+187% +$139K ﹤0.01% 479
2024
Q4
$75.9K Sell
1,025
-62,335
-98% -$4.62M ﹤0.01% 518
2024
Q3
$4.18M Sell
63,360
-1,873
-3% -$124K 0.01% 282
2024
Q2
$6.03M Sell
65,233
-1,432
-2% -$132K 0.01% 270
2024
Q1
$6.37M Sell
66,665
-2,356
-3% -$225K 0.01% 274
2023
Q4
$5.26M Buy
69,021
+19,750
+40% +$1.51M 0.01% 288
2023
Q3
$3.41M Sell
49,271
-364
-0.7% -$25.2K 0.01% 317
2023
Q2
$4.68M Sell
49,635
-719
-1% -$67.8K 0.01% 298
2023
Q1
$4.17M Buy
50,354
+975
+2% +$80.7K 0.01% 301
2022
Q4
$3.68M Sell
49,379
-2,090
-4% -$156K 0.01% 312
2022
Q3
$4.25M Buy
+51,469
New +$4.25M 0.01% 293
2022
Q2
Sell
-40
Closed -$5K 627
2022
Q1
$5K Buy
+40
New +$5K ﹤0.01% 564
2020
Q3
Sell
-63
Closed -$4K 538
2020
Q2
$4K Hold
63
﹤0.01% 465
2020
Q1
$4K Hold
63
﹤0.01% 466
2019
Q4
$5K Hold
63
﹤0.01% 454
2019
Q3
$5K Hold
63
﹤0.01% 427
2019
Q2
$4K Buy
+63
New +$4K ﹤0.01% 440
2017
Q1
Sell
-64,197
Closed -$2.01M 337
2016
Q4
$2.01M Buy
64,197
+5,067
+9% +$158K 0.02% 254
2016
Q3
$2.38M Buy
59,130
+6,033
+11% +$242K 0.03% 237
2016
Q2
$1.77M Sell
53,097
-9,966
-16% -$331K 0.03% 244
2016
Q1
$1.86M Buy
63,063
+7,107
+13% +$209K 0.03% 231
2015
Q4
$1.47M Sell
55,956
-30,342
-35% -$799K 0.02% 242
2015
Q3
$2.05M Buy
86,298
+5,670
+7% +$134K 0.03% 209
2015
Q2
$1.91M Buy
80,628
+10,626
+15% +$252K 0.03% 218
2015
Q1
$1.66M Sell
70,002
-1,674
-2% -$39.7K 0.03% 225
2014
Q4
$1.52M Sell
71,676
-5,664
-7% -$120K 0.03% 229
2014
Q3
$1.32M Sell
77,340
-21,492
-22% -$366K 0.02% 232
2014
Q2
$1.41M Sell
98,832
-6,942
-7% -$99.3K 0.02% 223
2014
Q1
$1.31M Buy
105,774
+7,914
+8% +$97.9K 0.02% 225
2013
Q4
$1.07M Buy
97,860
+26,916
+38% +$295K 0.02% 227
2013
Q3
$823K Buy
+70,944
New +$823K 0.02% 232